Stay updated on INCMGA00012, INCB001158 Combo in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the INCMGA00012, INCB001158 Combo in Advanced Solid Tumors Clinical Trial page.

Latest updates to the INCMGA00012, INCB001158 Combo in Advanced Solid Tumors Clinical Trial page
- ChecktodayNo Change Detected
 - Check8 days agoChange DetectedNo significant content changes detected on the Study Details page for NCT03910530; the study overview, eligibility criteria, design, and locations remain as described. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

 - Check29 days agoChange DetectedUpdates include a crucial operating-status notice related to government funding and an upgrade to version v3.2.0, replacing the previous v3.1.0.SummaryDifference3%

 - Check36 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.1%

 - Check50 days agoChange DetectedUpdated to revision v3.0.2, replacing v3.0.1. The removal of the 'Back to Top' element is a minor UI change; there are no substantive changes to core content, pricing, or availability.SummaryDifference0.2%

 - Check58 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.2%

 - Check65 days agoChange DetectedThe web page has updated its facility name and location details, specifically changing the representation of Chūōku, Japan, and has added drug information for Retifanlimab. Additionally, the revision number has been updated to v3.0.0.SummaryDifference1%

 
Stay in the know with updates to INCMGA00012, INCB001158 Combo in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INCMGA00012, INCB001158 Combo in Advanced Solid Tumors Clinical Trial page.